Both are effective for weight loss and have the same side effects, but one version may be more convenient for you.

Federal regulators have approved a new, higher-dose version of the obesity drug Wegovy that may help users lose more weight and keep it off. The U.S. Food and Drug Administration approved a ...

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in GLP-1 ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs ...

As the use of glucagon-like peptide-1 (GLP-1) agonists for weight loss continues to grow, there has also been a steady increase in research examining GLP-1s and their potential impact on other areas ...

Drug pricing in the U.S. has always been complex, and having more prices be public may make it hard for patients to understand Prices are going down for Novo Nordisk's weight-loss drug Wegovy. How ...